Abstract: The present disclosure relates to a composition for improving skin appearance such as skin lightening, anti-aging, and reduction in hyper pigmented dark spots on the skin. In particular, the present disclosure relates to a composition comprising a combination of 6, 7, 4’ trihydroxyisoflavone and dihydrooxyresveratrol. The present disclosure also provides a formulation comprising said composition and methods for preparing and using the same.
Claims:1. A composition for modulating age-related skin pigmentation, said composition comprising:
a. 6, 7, 4’ trihydroxyisoflavone; and
b. dihydrooxyresveratrol,
wherein 6, 7, 4 trihydroxyisoflavone to dihydrooxyresveratrol molar ratio in said composition is in the range of 1:0.5 to1:1.5.
2. The composition as claimed in claim 1, wherein 6, 7, 4 trihydroxyisoflavone to dihydrooxyresveratrol molar ratio in said composition is 1:1.
3. A topical formulation for modulating age-related skin pigmentation, said formulation comprising:
a. 6, 7, 4 trihydroxyisoflavone;
b. dihydrooxyresveratrol; and
c. at least one suitable carrier, diluent, and excipient,
wherein 6, 7, 4 trihydroxyisoflavone to dihydrooxyresveratrol molar ratio in said composition is in the range of 1:0.5 to 1:1.5.
4. The topical formulation as claimed in claim 3, wherein 6, 7, 4 trihydroxy isoflavone to dihydrooxyresveratrol molar ratio in said formulation is 1:1.
5. A method of cosmetic skin lightening, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-2; and
b. contacting said composition with skin,
wherein said method results in cosmetic skin lightening.
6. A method of cosmetic skin lightening, said method comprising:
a. obtaining a topical formulation as claimed in any of the claims 3-4; and
b. contacting said formulation with skin,
wherein said method results in cosmetic skin lightening.
7. A method of preparing a composition as claimed in any of the claims 1-2.
8. A method of preparing a topical formulation as claimed in any of the claims 3-4.
9. A composition as claimed in any of the claims 1-2, or the formulation as claimed in any of the claims 3-4 for topical use in cosmetic skin lightening.
, Description:N/A
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 7011-CHE-2015-RELEVANT DOCUMENTS [20-09-2023(online)].pdf | 2023-09-20 |
| 1 | Form 5 [28-12-2015(online)].pdf | 2015-12-28 |
| 2 | 7011-CHE-2015-RELEVANT DOCUMENTS [29-09-2022(online)].pdf | 2022-09-29 |
| 2 | Form 3 [28-12-2015(online)].pdf | 2015-12-28 |
| 3 | Drawing [28-12-2015(online)].pdf | 2015-12-28 |
| 3 | 7011-CHE-2015-US(14)-HearingNotice-(HearingDate-25-01-2021).pdf | 2021-10-17 |
| 4 | Description(Complete) [28-12-2015(online)].pdf | 2015-12-28 |
| 4 | 7011-CHE-2015-IntimationOfGrant23-02-2021.pdf | 2021-02-23 |
| 5 | 7011-CHE-2015-Power Of Attorney-030216.pdf | 2016-06-28 |
| 5 | 7011-CHE-2015-PatentCertificate23-02-2021.pdf | 2021-02-23 |
| 6 | 7011-CHE-2015-Written submissions and relevant documents [08-02-2021(online)].pdf | 2021-02-08 |
| 6 | 7011-CHE-2015-Form-1-030216.pdf | 2016-06-28 |
| 7 | 7011-CHE-2015-Correspondence-F1-PA-030216.pdf | 2016-06-28 |
| 7 | 7011-CHE-2015-Correspondence to notify the Controller [22-01-2021(online)].pdf | 2021-01-22 |
| 8 | 7011-CHE-2015-FORM 18 [03-11-2019(online)].pdf | 2019-11-03 |
| 8 | 7011-CHE-2015-DRAWING [26-11-2020(online)].pdf | 2020-11-26 |
| 9 | 7011-CHE-2015-FER.pdf | 2020-02-28 |
| 9 | 7011-CHE-2015-FER_SER_REPLY [26-11-2020(online)].pdf | 2020-11-26 |
| 10 | 7011-CHE-2015-FORM 4(ii) [21-08-2020(online)].pdf | 2020-08-21 |
| 10 | 7011-CHE-2015-OTHERS [26-11-2020(online)].pdf | 2020-11-26 |
| 11 | 7011-CHE-2015-FORM 4(ii) [21-08-2020(online)].pdf | 2020-08-21 |
| 11 | 7011-CHE-2015-OTHERS [26-11-2020(online)].pdf | 2020-11-26 |
| 12 | 7011-CHE-2015-FER.pdf | 2020-02-28 |
| 12 | 7011-CHE-2015-FER_SER_REPLY [26-11-2020(online)].pdf | 2020-11-26 |
| 13 | 7011-CHE-2015-DRAWING [26-11-2020(online)].pdf | 2020-11-26 |
| 13 | 7011-CHE-2015-FORM 18 [03-11-2019(online)].pdf | 2019-11-03 |
| 14 | 7011-CHE-2015-Correspondence to notify the Controller [22-01-2021(online)].pdf | 2021-01-22 |
| 14 | 7011-CHE-2015-Correspondence-F1-PA-030216.pdf | 2016-06-28 |
| 15 | 7011-CHE-2015-Form-1-030216.pdf | 2016-06-28 |
| 15 | 7011-CHE-2015-Written submissions and relevant documents [08-02-2021(online)].pdf | 2021-02-08 |
| 16 | 7011-CHE-2015-PatentCertificate23-02-2021.pdf | 2021-02-23 |
| 16 | 7011-CHE-2015-Power Of Attorney-030216.pdf | 2016-06-28 |
| 17 | 7011-CHE-2015-IntimationOfGrant23-02-2021.pdf | 2021-02-23 |
| 17 | Description(Complete) [28-12-2015(online)].pdf | 2015-12-28 |
| 18 | Drawing [28-12-2015(online)].pdf | 2015-12-28 |
| 18 | 7011-CHE-2015-US(14)-HearingNotice-(HearingDate-25-01-2021).pdf | 2021-10-17 |
| 19 | Form 3 [28-12-2015(online)].pdf | 2015-12-28 |
| 19 | 7011-CHE-2015-RELEVANT DOCUMENTS [29-09-2022(online)].pdf | 2022-09-29 |
| 20 | Form 5 [28-12-2015(online)].pdf | 2015-12-28 |
| 20 | 7011-CHE-2015-RELEVANT DOCUMENTS [20-09-2023(online)].pdf | 2023-09-20 |
| 1 | SS7011CHE2015_27-02-2020.pdf |